1026 related articles for article (PubMed ID: 28135901)
1. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
2. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Liposomal Nanotechnology for Cancer Theranostics.
Yue X; Dai Z
Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
[TBL] [Abstract][Full Text] [Related]
5. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
6. Towards tailored management of malignant brain tumors with nanotheranostics.
Aparicio-Blanco J; Torres-Suárez AI
Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
[TBL] [Abstract][Full Text] [Related]
7. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.
Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Feb; 10(2):151-5. PubMed ID: 23061654
[TBL] [Abstract][Full Text] [Related]
8. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.
Sonali ; Singh RP; Singh N; Sharma G; Vijayakumar MR; Koch B; Singh S; Singh U; Dash D; Pandey BL; Muthu MS
Drug Deliv; 2016 May; 23(4):1261-71. PubMed ID: 26961144
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
10. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
Seleci M; Ag Seleci D; Scheper T; Stahl F
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
[TBL] [Abstract][Full Text] [Related]
11. Interlocked systems in nanomedicine.
Ornelas-Megiatto C; Becher TB; Megiatto JD
Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
[TBL] [Abstract][Full Text] [Related]
12. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
Muthu MS; Leong DT; Mei L; Feng SS
Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
[TBL] [Abstract][Full Text] [Related]
13. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
14. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
Caldorera-Moore ME; Liechty WB; Peppas NA
Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
[TBL] [Abstract][Full Text] [Related]
15. RGD-TPGS decorated theranostic liposomes for brain targeted delivery.
Sonali ; Singh RP; Sharma G; Kumari L; Koch B; Singh S; Bharti S; Rajinikanth PS; Pandey BL; Muthu MS
Colloids Surf B Biointerfaces; 2016 Nov; 147():129-141. PubMed ID: 27497076
[TBL] [Abstract][Full Text] [Related]
16. Functionalized magnetic nanoparticles for biomedical applications.
Gudovan D; Balaure PC; Mihăiescu DE; Fudulu A; Purcăreanu B; Radu M
Curr Pharm Des; 2015; 21(42):6038-54. PubMed ID: 26503153
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
18. Nanotheranostics, a future remedy of neurological disorders.
Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
[TBL] [Abstract][Full Text] [Related]
19. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Lammers T; Kiessling F; Hennink WE; Storm G
Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
[TBL] [Abstract][Full Text] [Related]
20. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
